Urinary oxalate excretion increases with body size and decreases with increasing dietary calcium intake among healthy adults

Kidney International

Volumn 49, Issue 1, 1996, Pages 200-208

  Lemann Jr , Jacob ^a   Pleuss, Joan A ^a   Worcester, Elaine M ^a   Hornick, Laurel ^a   Schrab, Debra ^a   Hoffmann, Raymond G ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

OXALIC ACID;

ADULT; AGED; ARTICLE; BODY SIZE; CALCIUM INTAKE; CLINICAL TRIAL; DIET; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PRIORITY JOURNAL; URINARY EXCRETION;

EID: 0030052704     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1996.27     Document Type: Article

References (33)

1. PRIEN EL, FRONDEL C: Studies in urolithiasis. I. Composition of urinary calculi. J Urol 57:949-994, 1947
2. MANDEL NS, MANDEL GS: Urinary tract stone disease in the United States veteran population: II Geographical variation in composition. J Urol 142:1516-1521, 1989
3. FINLAYSON B: Calcium stones: Sonic physical and clinical aspects (Chapt 10), in Calcium Metabolism in Renal Failure and Nephrolithiasis, edited by DAVID DS, New York, John Wiley & Sons, 1977, pp 337-382
4. WYNGAARDEN JB, ELDER TD: Primary hyperoxaluria and oxalosis, in The Metabolic Basis of Inherited Disease (2nd ed), edited by STANBURY JB, WYNGAAEDEN JB, FREDRICKSON DS, New York, McGraw-Hill, 1966, pp 189-212
5. SMITH LH: Hyperoxaluric states (Chapt 33), in Disorders of Bone and Mineral Metabolism, edited by COE FL, FAVUS MJ, New York, Raven Press, 1992, pp 707-727
6. ZAREMBSKI ZM, HODGKINSON A: Some factors influencing the urinary excretion of oxalate in man. Clin Chim Acta 25:1-10, 1969
7. MARSHALL RW, COCHRAN M, HODGKINSON A: Relationships between calcium and oxalic acid intake in the diet and their excretion in the urine of normal and renal-stone-forming subjects. Clin Sci 43:91-99, 1972
8. BATAILLE P, CHARRANSOL G, GREGOIRE I, DAIGRE JL, COEVOET B, MAKDASSI R, PRUNA A, LOCQUET P, SUEUR JP, FOURNIERK P: Effect of calcium restriction on renal excretion of oxalate and the probability of stones in the various pathophysiological groups with calcium stones. J Urol 130:218-223, 1983
9. LEMANN J JR, PLEUSS JA, GRAY RW: Increased dietary calcium intake reduces urinary oxalate excretion in healthy adults, in Urolithiasis, edited by WALKER V, SUTTON RAL, CAMERON ECB, PAK CYC, ROBERTSON WG, New York, Plenum Press, 1989, pp 435-438
10. MASSEY LK, SUTTON RAL: Modification of dietary oxalate and calcium reduces urinary oxalate in hyperoxaluric patients with kidney stones. J Am Diet Assoc 93:1305-1307, 1993
11. CURHAN GC, WILLETT WC, RIMM EB, STAMPFER MJ: A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stones. N Engl J Med 328:833-838, 1993
12. LEMANN J JR, HORNICK LJ, PLEUSS JA, GRAY RW: Oxalate is overestimated in alkaline urines collected during administration of bicarbonate with no specimen pH adjustment. Clin Chem 35:2107-2110, 1989
13. WILLETT WC, SAMPSON L, STAMPFER MJ, ROSNER B, BAIN C, WITSCHI J, HENNEKENS CH, SPEIZER FE: Reproducibility and validity of a semiquantitative food frequency questionnaire. Am J Epidemiol 122: 51-65, 1985
14. WILLETT W, STAMPFER MJ: Total energy intake: Implications for epidemiologic analyses. Am J Epidemiol 124:17-27, 1986
15. WILLETT WC, SAMPSON L, BROWNE ML, STAMPFER MJ, ROSNER B, HENNEKENS CH, SPEIZER FE: The use of a self-administered questionnaire to assess diet four years in the past. Am J Epidemiol 127:188-199, 1988
16. FESKANICH D, RIMM EB, GIOVANNUCCI EL, COLDITZ GA, STAMPFER MJ, LITIN LB, WILLET WC: Reproducibility and validity of intake measurements from a semiquantitative food frequency questionnaire. J Am Diet Assoc 93:790-796, 1993
17. MAZZACHI BC, TEUBNER JK, RYALL RL: Factors affecting measurements of urinary oxalate. Clin Chem 30:1339-1343, 1984
18. CHALMERS AH, COWLEY DM, MCWHINNEY BC: Stability of ascorbate in urine: Relevance to analyses for ascorbate and oxalate. Clin Chem 31:1703-1705, 1985
19. LEMANN J JR, GRAY RW, PLEUSS JA: Potassium bicarbonate, but not sodium bicarbonate, reduces urinary calcium excretion and improves calcium balance in healthy men. Kidney Int 35:688-695, 1989
20. KASIDAS GP, ROSE GA: Continuous-flow assay for urinary oxalate using immobilized oxalate oxidase. Ann Clin Biochem 24:412-419, 1985
21. WILSON DM, LIEDTKE RR: Modified enzyme-based colorimetric assay of urinary and plasma oxalate with improved sensitivity and no ascorbate interference: Reference values and sample handling procedures. Clin Chem 37:1229-1235, 1991
22. BERGLUND F, SÖRBO B: Turbidimetric analysis of inorganic sulphate in serum plasma and urine. Scand J Clin Lab Invest 12:147-153, 1960
23. MOELLERING H, GRUBER W: Determination of citrate with citrate lyase. Anal Biochem 17:369-376, 1966
24. LEMANN J JR, PLEUSS JA, GRAY RW, HOFFMAN RG: Potassium administration reduces and potassium deprivation increases urinary calcium excretion in healthy adults. Kidney Int 39:973-983, 1991
25. LEMANN J JR, PLEUSS JA: (unpublished observations)
26. WERNESS P, BROWN CM, SMITH LH, FINLAYSON B: Equil2: A BASIC Computer program for the calculation of urinary saturation. J Urol 134:1242-1244, 1985
27. COCKCROFT SW, GAULT HM: Prediction of creatinine clearances from serum creatinine. Nephron 16:31-41, 1976
28. PARKS JH, COE FL: A urinary calcium-citrate index for the evaluation of nephrolithiasis. Kidney Int 30:85-90, 1986
29. ROBERSTON WG, NISA M, HUSAIN I, AL-FAQHI S, CHAKRABARTY A, QUNBI W, TAHER S, HUGHES H, BARKWORTH SA, HOLBROW G, LOUIS S: The importance of diet in the etiology of primary calcium and uric acid stone formation: The Arabian experience, in Urolithiasis, edited WALKER V, SUTTON RAL, CAMERON ECB, PAK CYC, ROBERTSON WG, New York, Plenum Press, 1989, pp 735-739
30. ROBERTSON WG, OUNIBI W, HUSAIN, HUGHES H, WALKER VR, TAHER S, BARKWORTH SA, HOLBROW G, LOUIS S: The calculation of stone risk in the urine of Middle Eastern men and Western expatriates living in Saudi Arabia, in Urolithiasis, edited by WALKER V. SUTTON RAL, CAMERON ECB, PAK CYC, ROBERTSON WG, New York, Plenum Press, 1989, pp 669-671
31. SHIRAGA H, MIN W, VANDUSEN WJ, CLAYMAN MD, MINER D, TERRELL CH, SHERBOTIE JR: In vivo by uropontin: Another member of the aspartic acid-rich protein superfamily. Proc Natl Acad Sci USA 84:426-430, 1992
32. WORCESTER EM, BLUMENTHAL SS, BESHENSKY AM, LEWAND DL: The calcium oxalate crystal growth inhibitor protein produced by mouse kidney cortical cells in culture is osteopontin. J Bone Miner Res 7:1024-1036, 1992
33. NAKAGAWA Y, ABRAM V, KUZDY FJ, KAISER ET, COE FL: Purification and characterization of the principal inhibitor of calcium oxalate monohydrate crystal growth in human urine. J Biol Chem 258:12594-125600, 1983